It is a pharma private limited company based in New Delhi, Delhi, India, established in 1989.
1989 | New Delhi, Delhi, India | Struck OffMedronas Pharmaceuticals Private Limited, a struck off private limited company, was established on 16 November 1989 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74899DL1989PTC038350. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.13 M.
Formerly known as Allen Chemicals Private Limited. It upholds a compliant status. Its leadership includes Ankur Allen (Director), Ravindra Allen (Director). Past directors included Ankur Allen, Abha Allen. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 64-D, Lig Pocket-12, Jasola Vihar, New Delhi, Delhi, 110025.
U74899DL1989PTC038350
038350
16 November 1989
₹0.50 M
₹0.13 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Medronas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankur Allen | Director | 23 May 2020 | Current |
| Ravindra Allen | Director | 01 Jul 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Aug 2018 | Past |
| Pramod Abcsdd | Director | 23 May 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medronas Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Medronas Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medronas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medronas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medronas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Medronas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.
Progress on Medronas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi. was documented.
The activity Ankur Allen was appointed as a Director was appointed as a Director on 23 May 2020 & has been associated with this company since 5 years 6 months . was completed.
Ravindra Allen was appointed as a Director was appointed as a Director on 01 Jul 2004 & has been associated with this company since 21 years 5 months . was recorded as a recent event.
Progress on Medronas Pharmaceuticals Private Limited was registered on 16 Nov 1989 with Roc Delhi & aged 36 years 14 days as per MCA records. was documented.
The CIN of Medronas Pharmaceuticals Private Limited is U74899DL1989PTC038350.
Medronas Pharmaceuticals Private Limited is headquartered at 64-D, Lig Pocket-12, Jasola Vihar, New Delhi, Delhi, 110025.
Medronas Pharmaceuticals Private Limited was incorporated on 16 November 1989.
The current directors of Medronas Pharmaceuticals Private Limited are
The primary industry of Medronas Pharmaceuticals Private Limited is Pharma.
Medronas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medronas Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.13 M.
The compliance status of Medronas Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX